Melanocytic nevus - Cudurka Melanocytichttps://en.wikipedia.org/wiki/Nevus
Cudurka Melanocytic (Melanocytic nevus) waa nooc ka mid ah buro melanocytic oo ka kooban unugyada nevus. Inta badan nevi waxay soo baxaan labaatanka sano ee ugu horreeya nolosha qofka. Iyadoo 100kii ilmoodba mid uu ku dhasho nevi. Nevi la helay waa nooc ka mid ah neoplasm aan fiicneyn, halka nevi lagu dhasho loo tixgeliyo cillad yar ama hamartoma waxaana laga yaabaa inay khatar sare ugu jirto melanoma. Nevus benign waa wareeg ama oval waxayna badanaa yar yihiin (badanaa inta u dhaxaysa 1-3 mm), inkastoo qaarkood ay ka weynaan karaan cabbirka tir tiriyaha caadiga ah (5 mm). Nevi qaar baa timo leh.

○ Daawaynta
Qalliinka laser-ka ayaa caadi ahaan loo sameeyaa in si qurxin ah looga saaro nevi yar. Haddii cabbirku ka weyn yahay 4-5 mm, goyn qalliin ayaa loo baahan karaa. Carruurta yaryar, nevus ka weyn 2 mm oo cabbirkiisu badanaa way adag tahay in si buuxda loo saaro iyada oo aan nabar lahayn.
#CO2 laser
#Er-YAG laser
☆ Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo.
  • nevus caadiga ah
  • Becker nevus ― Garabka; oo lagu garto koritaanka timaha nevuska.
  • Nevus of Ota ― Wuxuu u muuqdaa buluug sababtoo ah meesha qoto dheer ee unugyada nevus ee lakabka maqaarka. Xaaladda bukaankan, nevus wuxuu ku yaalaa conjunctiva. Ota nevus waxaa lagaga saari karaa daawaynta laysarka.
  • Compound nevus ― barida. Calaamadaha dhalashada yaryar waxay kori karaan nevi weyn marka ay da'da yihiin.
  • Intradermal nevus ― Qaabka nodule soo baxay.
  • nevus caadiga ah. Labada sawir ee hoose waa intradermal nevus, saddexda sawir ee korena waa junctional nevus.
  • Blue nevus ― Meesha qoto dheer ee unugyada nevus awgeed, waxay u muuqataa buluug.
  • Intradermal nevus ― Waxaa badanaa lagu arkaa madaxa.
  • Sawirkaani wuxuu muujinayaa dhaawac nevus ah. Si kastaba ha noqotee, haddii dhaawaca ugu weyni uu yar yahay sidaan oo kale, algorithm-ka waxaa laga yaabaa inuusan awoodin inuu si sax ah u saadaaliyo xaaladda.
References Effective Treatment of Congenital Melanocytic Nevus and Nevus Sebaceous Using the Pinhole Method with the Erbium-Doped Yttrium Aluminium Garnet Laser 25324667 
NIH
Congenital melanocytic nevus waa nevus melanocytic ah kaas oo jira xilliga dhalashada ama muuqda inta lagu jiro marxaladaha dambe ee dhallaanka. Nevus sebaceous waxaa lagu tilmaamay inay tahay meesha hamartomatous ee unugga pilosebaceous cilladaysan ee uurjiifka. Halkan, waxaan ku sharaxaynaa sida aan u isticmaalnay farsamada pinhole leh Erbium:YAG laser si loogu daweeyo dhaawacyada nevi ee bukaanada kala duwan.
Congenital melanocytic nevus (CMN) is a melanocytic nevus that is either present at birth or appears during the latter stages of infancy. Nevus sebaceous has been described as the hamartomatous locus of an embryologically defective pilosebaceous unit. Here, we describe how we used the pinhole technique with an erbium-doped yttrium aluminium garnet (erbium : YAG) laser to treat nevi lesions in different patients.
 Malignant Melanoma 29262210 
NIH
Melanoma waa nooc ka mid ah burooyinka oo sameysma marka melanocytes, unugyada ka masuulka ah midabka maqaarka, noqdaan kansar. Melanocytes waxay ka soo jeedaan qolofta neerfaha. Tani waxay ka dhigan tahay in melanomas aysan ku kori karin maqaarka oo kaliya laakiin sidoo kale meelaha kale ee unugyada neerfaha neerfaha ay u haajiraan, sida mareenka caloosha iyo mindhicirka iyo maskaxda. Heerka badbaadada ee bukaanada qaba melanoma marxaladda hore (marxaladda 0) aad ayay u saraysaa 97%, halka ay aad hoos ugu dhacayso ilaa 10% kuwa laga helay cudurka marxaladda hore (marxaladda IV) .
A melanoma is a tumor produced by the malignant transformation of melanocytes. Melanocytes are derived from the neural crest; consequently, melanomas, although they usually occur on the skin, can arise in other locations where neural crest cells migrate, such as the gastrointestinal tract and brain. The five-year relative survival rate for patients with stage 0 melanoma is 97%, compared with about 10% for those with stage IV disease.